Literature DB >> 23032617

Toward an improved definition of the tumor spectrum associated with BAP1 germline mutations.

Thomas Wiesner1, Isabella Fried, Peter Ulz, Elvira Stacher, Helmut Popper, Rajmohan Murali, Heinz Kutzner, Sigurd Lax, Freya Smolle-Jüttner, Jochen B Geigl, Michael R Speicher.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23032617     DOI： 10.1200/JCO.2011.41.2965

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  34 in total

Review 1.  BAP1, a tumor suppressor gene driving malignant mesothelioma.

Authors:  Mitchell Cheung; Joseph R Testa
Journal:  Transl Lung Cancer Res       Date:  2017-06

2.  Melanoma With Loss of BAP1 Expression in Patients With No Family History of BAP1-Associated Cancer Susceptibility Syndrome: A Case Series.

Authors:  Phyu P Aung; Priyadharsini Nagarajan; Michael T Tetzlaff; Jonathan L Curry; Guilin Tang; Zied Abdullaev; Svetlana D Pack; Doina Ivan; Victor G Prieto; Carlos A Torres-Cabala
Journal:  Am J Dermatopathol       Date:  2019-03       Impact factor: 1.533

Review 3.  Familial risk of melanoma and links with other cancers.

Authors:  Kachiu C Lee; H William Higgins; Abrar A Qureshi
Journal:  Melanoma Manag       Date:  2015-02-25

4.  Germline mutation of Bap1 accelerates development of asbestos-induced malignant mesothelioma.

Authors:  Jinfei Xu; Yuwaraj Kadariya; Mitchell Cheung; Jianming Pei; Jacqueline Talarchek; Eleonora Sementino; Yinfei Tan; Craig W Menges; Kathy Q Cai; Samuel Litwin; Hongzhuang Peng; Jayashree Karar; Frank J Rauscher; Joseph R Testa
Journal:  Cancer Res       Date:  2014-06-13       Impact factor: 12.701

Review 5.  BAP1 mutations in high-grade meningioma: implications for patient care.

Authors:  Ganesh M Shankar; Sandro Santagata
Journal:  Neuro Oncol       Date:  2017-10-19       Impact factor: 12.300

6.  Mesothelioma patients with germline BAP1 mutations have 7-fold improved long-term survival.

Authors:  Francine Baumann; Erin Flores; Andrea Napolitano; Shreya Kanodia; Emanuela Taioli; Harvey Pass; Haining Yang; Michele Carbone
Journal:  Carcinogenesis       Date:  2014-11-07       Impact factor: 4.944

Review 7.  Connecting molecular pathways to hereditary cancer risk syndromes.

Authors:  Joseph R Testa; David Malkin; Joshua D Schiffman
Journal:  Am Soc Clin Oncol Educ Book       Date:  2013

8.  A novel germline mutation in BAP1 predisposes to familial clear-cell renal cell carcinoma.

Authors:  Megan N Farley; Laura S Schmidt; W Marston Linehan; James Brugarolas; Jessica L Mester; Samuel Pena-Llopis; Andrea Pavia-Jimenez; Alana Christie; Cathy D Vocke; Christopher J Ricketts; James Peterson; Lindsay Middelton; Lisa Kinch; Nick Grishin; Maria J Merino; Adam R Metwalli; Chao Xing; Xian-Jin Xie; Patricia L M Dahia; Charis Eng
Journal:  Mol Cancer Res       Date:  2013-05-24       Impact factor: 5.852

9.  Effect of a detailed family history of melanoma on risk for other tumors: a cohort study based on the nationwide Swedish Family-Cancer Database.

Authors:  Tianhui Chen; Mahdi Fallah; Elham Kharazmi; Jianguang Ji; Kristina Sundquist; Kari Hemminki
Journal:  J Invest Dermatol       Date:  2013-11-05       Impact factor: 8.551

10.  BAP1 protein is a progression factor in malignant pleural mesothelioma.

Authors:  Lisa Arzt; Franz Quehenberger; Iris Halbwedl; Thomas Mairinger; Helmut H Popper
Journal:  Pathol Oncol Res       Date:  2013-08-22       Impact factor: 3.201
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.